Viridian Therapeutics's total assets for Q3 2024 were $771.90M, an increase of 31.80% from the previous quarter. GB:0K1R total liabilities were $64.40M for the fiscal quarter, a 14.34% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.